Identification of several plasma proteins whose levels in colorectal cancer patients differ depending on outcome

Identification of several plasma proteins whose levels in colorectal cancer patients differ depending on outcome

Abstract Colorectal cancer (CRC) stands for 10% of the worldwide cancer burden and has recently become the second most common cause of cancer death. The 5‐year survival rate depends mainly on stage at diagnosis. Mass spectrometric proteomic analysis is widely used to study the plasma proteome, which...

Full description

Bibliographic Details
Main Authors: Matilda Holm, Sakari Joenväärä, Mayank Saraswat, Harri Mustonen, Tiialotta Tohmola, Ari Ristimäki, Risto Renkonen, Caj Haglund
Format: Article
Language:English
Published: Wiley 2019-12-01
Series:FASEB BioAdvances
Subjects:
mass spectrometry
outcome
plasma proteome
proteomics
stage
Online Access:https://doi.org/10.1096/fba.2019-00062

Internet

https://doi.org/10.1096/fba.2019-00062

Similar Items